Published in Infect Immun on December 01, 1996
Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance. Clin Microbiol Rev (2002) 2.20
Capsule polysaccharide mediates bacterial resistance to antimicrobial peptides. Infect Immun (2004) 2.14
Dissection of host cell signal transduction during Acinetobacter baumannii-triggered inflammatory response. PLoS One (2010) 1.06
Intraspecific comparative analysis of the species Salinibacter ruber. Extremophiles (2005) 1.00
Quinolones sensitize gram-negative bacteria to antimicrobial peptides. Antimicrob Agents Chemother (2006) 0.97
Pathogenic Yersinia enterocolitica strains increase the outer membrane permeability in response to environmental stimuli by modulating lipopolysaccharide fluidity and lipid A structure. Infect Immun (2003) 0.95
Characterization and biological role of the O-polysaccharide gene cluster of Yersinia enterocolitica serotype O:9. J Bacteriol (2007) 0.90
Mechanisms of Antimicrobial Peptide Resistance in Gram-Negative Bacteria. Antibiotics (Basel) (2015) 0.90
Molecular basis of Yersinia enterocolitica temperature-dependent resistance to antimicrobial peptides. J Bacteriol (2012) 0.88
Characterization of the six glycosyltransferases involved in the biosynthesis of Yersinia enterocolitica serotype O:3 lipopolysaccharide outer core. J Biol Chem (2010) 0.82
Deciphering tissue-induced Klebsiella pneumoniae lipid A structure. Proc Natl Acad Sci U S A (2015) 0.81
Comparative antimicrobial activity of granulysin against bacterial biothreat agents. Open Microbiol J (2009) 0.81
Importance of Tryptophan in Transforming an Amphipathic Peptide into a Pseudomonas aeruginosa-Targeted Antimicrobial Peptide. PLoS One (2014) 0.75
The thiobarbituric acid assay of sialic acids. J Biol Chem (1959) 43.78
A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem (1978) 38.54
A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem (1982) 36.39
Molecular basis of bacterial outer membrane permeability. Microbiol Rev (1985) 17.75
A Salmonella locus that controls resistance to microbicidal proteins from phagocytic cells. Science (1989) 7.58
Agents that increase the permeability of the outer membrane. Microbiol Rev (1992) 7.52
Yersinia enterocolitica, a primary model for bacterial invasiveness. Rev Infect Dis (1987) 5.48
Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol (1993) 5.36
Expression of the temperature-inducible outer membrane proteins of yersiniae. Infect Immun (1985) 4.36
Alterations in outer membrane permeability. Annu Rev Microbiol (1984) 4.22
Yersinia enterocolitica. N Engl J Med (1989) 4.00
Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1984) 3.19
Plasmid-mediated and temperature-regulated surface properties of Yersinia enterocolitica. Infect Immun (1983) 3.13
Enteric defensins: antibiotic peptide components of intestinal host defense. J Cell Biol (1992) 3.03
Studies on the pathogenicity of Yersinia enterocolitica. I. Experimental infection in rabbits. Microbiol Immunol (1977) 2.99
Immunohistochemical and electron microscopic study of interaction of Yersinia enterocolitica serotype O8 with intestinal mucosa during experimental enteritis. Infect Immun (1989) 2.60
Antibacterial peptides from pig intestine: isolation of a mammalian cecropin. Proc Natl Acad Sci U S A (1989) 2.59
Peptides as weapons against microorganisms in the chemical defense system of vertebrates. Annu Rev Microbiol (1995) 2.43
Cryptdins: antimicrobial defensins of the murine small intestine. Infect Immun (1992) 2.39
Growth phase and low pH affect the thermal regulation of the Yersinia enterocolitica inv gene. Mol Microbiol (1994) 2.26
Environmental modulation of gene expression and pathogenesis in Yersinia. Trends Microbiol (1995) 2.22
The structure of Escherichia coli membranes studied by fluorescence measurements of lipid phase transitions. Biochim Biophys Acta (1973) 2.03
Mouse Paneth cell defensins: primary structures and antibacterial activities of numerous cryptdin isoforms. Infect Immun (1994) 1.93
Pathogenesis of defined invasion mutants of Yersinia enterocolitica in a BALB/c mouse model of infection. Infect Immun (1995) 1.92
The outer membranes of Brucella spp. are resistant to bactericidal cationic peptides. Infect Immun (1995) 1.82
Outer membrane permeability barrier disruption by polymyxin in polymyxin-susceptible and -resistant Salmonella typhimurium. Antimicrob Agents Chemother (1981) 1.79
Detection of pathogenic Yersinia enterocolitica by using congo red-magnesium oxalate agar medium. J Clin Microbiol (1989) 1.74
Serological cross-reactions between different Brucella species and Yersinia enterocolitica. Immunochemical studies on phenol-water extracted lipopolysaccharides from Brucella abortus and Yersinia enterocolitica type IX. Acta Pathol Microbiol Scand B Microbiol Immunol (1973) 1.66
Studies on the pathogenicity of Yersinia enterocolitica. III. Comparative studies between Y. enterocolitica and Y. pseudotuberculosis. Microbiol Immunol (1977) 1.64
Invasiveness of Yersinia enterocolitica lacking the virulence plasmid: an in-vivo study. J Med Microbiol (1987) 1.62
Plasmid-associated cell surface charge and hydrophobicity of Yersinia enterocolitica. Infect Immun (1984) 1.52
How bacteria resist killing by host-defense peptides. Trends Microbiol (1994) 1.48
The Myf fibrillae of Yersinia enterocolitica. Mol Microbiol (1993) 1.42
Adherence and toxicity of Yersinia enterocolitica 0:3 and 0:9 containing virulence-associated plasmids for various cultured cells. Acta Pathol Microbiol Immunol Scand B (1983) 1.41
Physical properties of short- and long-O-antigen-containing fractions of lipopolysaccharide from Escherichia coli 0111:B4. J Bacteriol (1986) 1.30
Humoral and cellular defense against intestinal murine infection with Yersinia enterocolitica. Infect Immun (1991) 1.28
LcrF is the temperature-regulated activator of the yadA gene of Yersinia enterocolitica and Yersinia pseudotuberculosis. J Bacteriol (1992) 1.25
MyfF, an element of the network regulating the synthesis of fibrillae in Yersinia enterocolitica. J Bacteriol (1995) 1.22
The outer membranes of Brucella spp. are not barriers to hydrophobic permeants. J Bacteriol (1993) 1.20
The effect of growth temperature on the biosynthesis of Yersinia enterocolitica O:3 lipopolysaccharide: temperature regulates the transcription of the rfb but not of the rfa region. Microb Pathog (1991) 1.13
Interaction of melittin with endotoxic lipid A. Biochim Biophys Acta (1992) 1.00
Ail expression in Yersinia enterocolitica is affected by oxygen tension. Infect Immun (1995) 0.90
Purification of lipopolysaccharide from strains of Yersinia enterocolitica belonging to serogroups 03 and 09. FEMS Microbiol Lett (1991) 0.85
Analysis by coagglutination of the distribution of a 24,000-dalton surface protein in Yersinia isolates. J Clin Microbiol (1986) 0.80
A two-component regulatory system playing a critical role in plant pathogens and endosymbionts is present in Brucella abortus and controls cell invasion and virulence. Mol Microbiol (1998) 2.60
Evaluation of the relatedness of Brucella spp. and Ochrobactrum anthropi and description of Ochrobactrum intermedium sp. nov., a new species with a closer relationship to Brucella spp. Int J Syst Bacteriol (1998) 2.11
Identification of components of a new stability system of plasmid R1, ParD, that is close to the origin of replication of this plasmid. Mol Gen Genet (1987) 1.88
The outer membranes of Brucella spp. are resistant to bactericidal cationic peptides. Infect Immun (1995) 1.82
Double versus single renal allografts from aged donors. Transplantation (2000) 1.58
Clinical predictors of in-hospital prognosis in unstable angina: ECLA 3. The ECLA Collaborative Group. Am Heart J (1999) 1.56
An ELISA with Brucella lipopolysaccharide antigen for the diagnosis of B. melitensis infection in sheep and for the evaluation of serological responses following subcutaneous or conjunctival B. melitensis strain Rev 1 vaccination. Vet Microbiol (1992) 1.50
Characterization of Brucella abortus and Brucella melitensis native haptens as outer membrane O-type polysaccharides independent from the smooth lipopolysaccharide. J Bacteriol (1996) 1.49
Brucella-Salmonella lipopolysaccharide chimeras are less permeable to hydrophobic probes and more sensitive to cationic peptides and EDTA than are their native Brucella sp. counterparts. J Bacteriol (1996) 1.47
The Myf fibrillae of Yersinia enterocolitica. Mol Microbiol (1993) 1.42
Comparative analysis of Brucella serotype A and M and Yersinia enterocolitica O:9 polysaccharides for serological diagnosis of brucellosis in cattle, sheep, and goats. J Clin Microbiol (1993) 1.38
Release of outer membrane fragments by exponentially growing Brucella melitensis cells. Infect Immun (1987) 1.32
Comparative analyses of proteins extracted by hot saline or released spontaneously into outer membrane blebs from field strains of Brucella ovis and Brucella melitensis. Infect Immun (1989) 1.32
Evaluation of serological tests for diagnosis of Brucella melitensis infection of goats. J Clin Microbiol (1994) 1.31
Killing of Escherichia coli cells modulated by components of the stability system ParD of plasmid R1. Mol Gen Genet (1988) 1.31
Antibody response to Brucella ovis outer membrane proteins in ovine brucellosis. Infect Immun (1990) 1.27
Brucella melitensis Rev-1 vaccine as a cause of human brucellosis. Lancet (1993) 1.25
Identification of 2,3-dihydroxybenzoic acid as a Brucella abortus siderophore. Infect Immun (1992) 1.24
The lipopolysaccharide outer core of Yersinia enterocolitica serotype O:3 is required for virulence and plays a role in outer membrane integrity. Mol Microbiol (1999) 1.24
Prism adaptation and aftereffect: specifying the properties of a procedural memory system. Learn Mem (1999) 1.23
Characterization of a Yersinia enterocolitica antigen common to enterocolitis-associated serotypes. J Clin Microbiol (1985) 1.23
[Contribution to the serological diagnosis of brucellosis and yersiniosis. I. Use of the gel precipitation reaction]. Rev Clin Esp (1971) 1.20
The outer membranes of Brucella spp. are not barriers to hydrophobic permeants. J Bacteriol (1993) 1.20
Brucella abortus and its closest phylogenetic relative, Ochrobactrum spp., differ in outer membrane permeability and cationic peptide resistance. Infect Immun (2000) 1.17
Demonstration of a peptidoglycan-linked lipoprotein and characterization of its trypsin fragment in the outer membrane of Brucella spp. Infect Immun (1986) 1.16
Comparison of lipopolysaccharide and outer membrane protein-lipopolysaccharide extracts in an enzyme-linked immunosorbent assay for the diagnosis of Brucella ovis infection. J Clin Microbiol (1986) 1.14
Factors affecting detection of Brucella melitensis by BACTEC NR730, a nonradiometric system for hemocultures. J Clin Microbiol (1993) 1.12
Efficacy of several serological tests and antigens for diagnosis of bovine brucellosis in the presence of false-positive serological results due to Yersinia enterocolitica O:9. Clin Diagn Lab Immunol (2005) 1.09
Evaluation of allergic and serological tests for diagnosing Brucella melitensis infection in sheep. J Clin Microbiol (1994) 1.09
Genetic and functional analysis of the basic replicon of pPS10, a plasmid specific for Pseudomonas isolated from Pseudomonas syringae patovar savastanoi. J Mol Biol (1992) 1.09
The outer membrane of Brucella ovis shows increased permeability to hydrophobic probes and is more susceptible to cationic peptides than are the outer membranes of mutant rough Brucella abortus strains. Infect Immun (1999) 1.09
Properties of the outer membrane of Brucella. Ann Inst Pasteur Microbiol (1987) 1.08
Molecular heterogeneity in chronic lymphocytic leukemia is dependent on BCR signaling: clinical correlation. Leukemia (2007) 1.06
Regulation of Brucella virulence by the two-component system BvrR/BvrS. Vet Microbiol (2002) 1.05
Brucella outer membrane lipoprotein shares antigenic determinants with Escherichia coli Braun lipoprotein and is exposed on the cell surface. Infect Immun (1987) 1.01
Yersinia pseudotuberculosis and Yersinia pestis are more resistant to bactericidal cationic peptides than Yersinia enterocolitica. Microbiology (1998) 1.00
[Study of the antigenic relations between Yersina enterocolitica serotype 9 and other gram negative bacterial strains]. Microbiol Esp (1974) 1.00
Evaluation of lipopolysaccharides and polysaccharides of different epitopic structures in the indirect enzyme-linked immunosorbent assay for diagnosis of brucellosis in small ruminants and cattle. Clin Diagn Lab Immunol (1998) 0.98
Brucella group 3 outer membrane proteins contain a heat-modifiable protein. FEMS Microbiol Lett (1993) 0.97
Yersinia pseudotuberculosis and Yersinia pestis show increased outer membrane permeability to hydrophobic agents which correlates with lipopolysaccharide acyl-chain fluidity. Microbiology (1998) 0.96
Differential binding of wild-type and a mutant RepA protein to oriR sequence suggests a model for the initiation of plasmid R1 replication. J Mol Biol (1992) 0.96
Enzyme-linked immunosorbent assay with Brucella native hapten polysaccharide and smooth lipopolysaccharide. J Clin Microbiol (1988) 0.96
Pathogenic Yersinia enterocolitica strains increase the outer membrane permeability in response to environmental stimuli by modulating lipopolysaccharide fluidity and lipid A structure. Infect Immun (2003) 0.95
Antibody and delayed-type hypersensitivity responses to Ochrobactrum anthropi cytosolic and outer membrane antigens in infections by smooth and rough Brucella spp. Clin Diagn Lab Immunol (1997) 0.95
Evaluation of whole cell and subcellular vaccines against Brucella ovis in rams. Vet Immunol Immunopathol (1993) 0.93
Percutaneous tracheostomy: Ciaglia Blue Rhino versus Griggs' Guide Wire Dilating Forceps. A prospective randomized trial. Acta Anaesthesiol Scand (2004) 0.93
Immunization with Brucella melitensis Rev 1 against Brucella ovis infection of rams. Vet Microbiol (1987) 0.92
Cerebellar ataxia associated with neuroendocrine thymic carcinoma and GAD antibodies. J Neurol Neurosurg Psychiatry (2009) 0.92
Development and evaluation of a rapid dipstick assay for serodiagnosis of acute human brucellosis. J Clin Microbiol (1999) 0.91
Structural studies on the lipopolysaccharide from a rough strain of Ochrobactrum anthropi containing a 2,3-diamino-2,3-dideoxy-D-glucose disaccharide lipid A backbone. Carbohydr Res (1998) 0.90
[Usefulness of Rose Bengal, Coombs and counter-immunoelectrophoresis for the diagnosis of human brucellosis cases with negative seroagglutination]. Enferm Infecc Microbiol Clin (2001) 0.88
Rose Bengal plate agglutination and counterimmunoelectrophoresis tests on spinal fluid in the diagnosis of Brucella meningitis. J Clin Microbiol (1978) 0.88
Learning motor synergies makes use of information on muscular load. Learn Mem (2000) 0.87
Correlates of HIV risk in a random sample of street youths in San Francisco. J Assoc Nurses AIDS Care (2001) 0.87
Midrapidity antiproton-to-proton ratio in pp collisons at sqrt[s]=0.9 and 7 TeV measured by the ALICE experiment. Phys Rev Lett (2010) 0.87
Large-scale production of recombinant hepatitis B surface antigen from Pichia pastoris. J Biotechnol (2000) 0.87
Factors determining the suspension of breast-feeding in an urban population group. Bull Pan Am Health Organ (1980) 0.87
Serological response to the outer membrane lipoprotein in animal brucellosis. Infect Immun (1988) 0.87
Antibiotic treatment induces an increase of the specific antibody levels in Brucella melitensis infected mice. FEMS Immunol Med Microbiol (1995) 0.86
Comparative activity of azithromycin and doxycycline against Brucella spp. infection in mice. J Antimicrob Chemother (1995) 0.86
(AC)23 [Z-2] polymorphism of the aldose reductase gene and fast progression of retinopathy in Chilean type 2 diabetics. Diabetes Res Clin Pract (2000) 0.85
Penicillium purpurogenum produces several xylanases: purification and properties of two of the enzymes. J Biotechnol (1995) 0.84
Cloning vectors, derived from a naturally occurring plasmid of Pseudomonas savastanoi, specifically tailored for genetic manipulations in Pseudomonas. Gene (1990) 0.84
Effects of involuntary auditory attention on visual task performance and brain activity. Neuroreport (1997) 0.82
Performance of competitive and indirect enzyme-linked immunosorbent assays, gel immunoprecipitation with native hapten polysaccharide, and standard serological tests in diagnosis of sheep brucellosis. Clin Diagn Lab Immunol (1999) 0.82
Isolation and characterization of a conditional replication mutant of the antibiotic resistance factor R1 affected in the gene of the replication protein repA. Mol Gen Genet (1989) 0.81
Effect of composition and method of preparation of liposomes on their stability and interaction with murine monocytes infected with Brucella abortus. Antimicrob Agents Chemother (1996) 0.81
Determination of the O-specific polysaccharide structure in the lipopolysaccharide of Ochrobactrum anthropi LMG 3331. Carbohydr Res (1996) 0.80
Comparison of three serological tests for Brucella ovis infection of rams using different antigenic extracts. Vet Rec (1989) 0.80
Epidemiological factors associated with the exposure of cattle to Coxiella burnetii in the Madrid region of Spain. Vet J (2012) 0.80
[Value of early anticoagulation in the prevention of intraventricular thrombosis after a 1st myocardial infarction: prospective and randomized study]. Rev Med Chil (1988) 0.80
Analysis by coagglutination of the distribution of a 24,000-dalton surface protein in Yersinia isolates. J Clin Microbiol (1986) 0.80
Differential gene expression in drug hypersensitivity reactions: induction of alarmins in severe bullous diseases. Br J Dermatol (2010) 0.80
An alternative to blunt-end ligation for cloning DNA fragments with incompatible ends. Trends Genet (1996) 0.79
[Brucellosis: study of 222 cases. IV. Diagnosis of human brucellosis]. Rev Clin Esp (1983) 0.79
Protective effect of liposomal gentamicin against systemic acute murine brucellosis. Chemotherapy (1997) 0.79
Kaposi's sarcoma in a patient with temporal arteritis treated with corticosteroid. J Am Acad Dermatol (1991) 0.79